• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶(CYP51)的对接研究。

In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.

作者信息

Rojas Vargas Julio Alberto, López América García, Pérez Yulier, Cos Paul, Froeyen Matheus

机构信息

Chemistry Department, Exact and Natural Science Faculty, Oriente University, Santiago de Cuba, Cuba.

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), S7, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, Belgium.

出版信息

Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.

DOI:10.1007/s00436-019-06206-z
PMID:30903349
Abstract

There is an urgent need to discover and develop new drugs to combat parasitic diseases as Chagas disease (Trypanosoma cruzi), sleeping sickness (Trypanosoma brucei), and leishmaniasis (Leishmania ssp.). These diseases are considered among the 13 most unattended diseases worldwide according to the WHO. In the present work, the synthesis of 14 arylsubstituted imidazoles and its molecular docking onto sterol 14α-demethylase (CYP51) was executed. In addition, the compounds, antiprotozoal activity against T. brucei, T. cruzi, Trypanosoma brucei rhodesiense, and Leishmania infantum was evaluated. In vitro antiparasitic results of the arylsubstituted imidazoles against T. brucei, T. cruzi, T.b. rhodesiense, and L. infantum indicated that all samples from arylsubstituted imidazole compounds presented interesting antiparasitic activity to various extent. The ligands 5a, 5c, 5e, 5f, 5g, 5i, and 5j exhibited strong activity against T. brucei, T. cruzi, T.b. rhodesiense, and L. infantum with IC values ranging from 0.86 to 10.23 μM. Most samples were cytotoxic against MRC-5 cell lines (1.12 < CC < 51.09 μM) and only ligand 5c showed a good selectivity against all tested parasites. According to the results of the molecular docking, the aromatic substituents in positions 1, 4, and 5 have mainly stabilizing hydrophobic interactions with the enzyme matrix, while the oxygen from NO, SOH, and OH groups interacts with the Fe ion of the Heme group.

摘要

迫切需要发现和开发新的药物来对抗寄生虫病,如恰加斯病(克氏锥虫)、昏睡病(布氏锥虫)和利什曼病(利什曼原虫属)。根据世界卫生组织的说法,这些疾病被认为是全球13种最被忽视的疾病之一。在本研究中,进行了14种芳基取代咪唑的合成及其与甾醇14α-脱甲基酶(CYP51)的分子对接。此外,还评估了这些化合物对布氏锥虫、克氏锥虫、罗德西亚布氏锥虫和婴儿利什曼原虫的抗原虫活性。芳基取代咪唑对布氏锥虫、克氏锥虫、罗德西亚布氏锥虫和婴儿利什曼原虫的体外抗寄生虫结果表明,芳基取代咪唑化合物的所有样品都表现出不同程度的有趣抗寄生虫活性。配体5a、5c、5e、5f、5g、5i和5j对布氏锥虫、克氏锥虫、罗德西亚布氏锥虫和婴儿利什曼原虫表现出较强的活性,IC值范围为0.86至10.23μM。大多数样品对MRC-5细胞系具有细胞毒性(1.12<CC<51.09μM),只有配体5c对所有测试寄生虫表现出良好的选择性。根据分子对接结果,1、4和5位的芳基取代基主要与酶基质形成稳定的疏水相互作用,而来自NO、SOH和OH基团的氧与血红素基团的Fe离子相互作用。

相似文献

1
In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶(CYP51)的对接研究。
Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.
2
Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.甾醇 14α-脱甲基酶(CYP51)作为人体利什曼病和锥虫病的治疗靶点。
Curr Top Med Chem. 2011;11(16):2060-71. doi: 10.2174/156802611796575902.
3
Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.利什曼原虫中的固醇 14α-脱甲基酶(CYP51)的结构特征决定的底物偏好性和催化参数。
J Biol Chem. 2011 Jul 29;286(30):26838-48. doi: 10.1074/jbc.M111.237099. Epub 2011 May 31.
4
Multitarget anti-parasitic activities of isoquinoline alkaloids isolated from Hippeastrum aulicum (Amaryllidaceae).从孤挺花(石蒜科)中分离得到的异喹啉生物碱的多靶点抗寄生虫活性。
Phytomedicine. 2024 Jun;128:155414. doi: 10.1016/j.phymed.2024.155414. Epub 2024 Feb 5.
5
In vitro antiprotozoal activity and cytotoxicity of extracts and fractions from the leaves, root bark and stem bark of Isolona hexaloba.六裂伊索龙叶、根皮和茎皮提取物及馏分的体外抗原生动物活性和细胞毒性
J Ethnopharmacol. 2015 Nov 4;174:187-94. doi: 10.1016/j.jep.2015.07.034. Epub 2015 Aug 1.
6
Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.咪唑类化合物作为抗寄生虫药物的生物评价及构效关系。
Eur J Med Chem. 2018 Aug 5;156:53-60. doi: 10.1016/j.ejmech.2018.06.063. Epub 2018 Jun 28.
7
Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity.基于多组分反应的具有多锥虫活性的三环杂环喹啉的合成及生物学评价
Eur J Med Chem. 2015 Nov 13;105:120-37. doi: 10.1016/j.ejmech.2015.10.007. Epub 2015 Oct 19.
8
Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.克氏锥虫甾醇 14α-脱甲基酶(CYP51)与两种用于恰加斯病的吡啶类药物候选物的复合物:病原体选择性的结构基础。
J Biol Chem. 2013 Nov 1;288(44):31602-15. doi: 10.1074/jbc.M113.497990. Epub 2013 Sep 18.
9
Hydrazinated geraniol derivatives as potential broad-spectrum antiprotozoal agents.水合香叶醇衍生物作为有潜力的广谱抗寄生虫药物。
Arch Pharm (Weinheim). 2024 Oct;357(10):e2400430. doi: 10.1002/ardp.202400430. Epub 2024 Jul 9.
10
In vitro activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease.沙特阿拉伯植物提取物抗疟疾、利什曼病、昏睡病和恰加斯病的体外活性。
Phytother Res. 2010 Sep;24(9):1322-8. doi: 10.1002/ptr.3108.

引用本文的文献

1
Inhibiting Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling.利用分子建模抑制甾醇甲基转移酶以鉴定先导化合物
Pharmaceuticals (Basel). 2023 Feb 21;16(3):330. doi: 10.3390/ph16030330.
2
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.针对动基体原生动物感染的基于靶点的药物设计概述:人类非洲锥虫病、恰加斯病和利什曼病
Molecules. 2021 Jul 30;26(15):4629. doi: 10.3390/molecules26154629.
3
Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant spp.

本文引用的文献

1
Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.在克氏锥虫Y株诱导的恰加斯病瑞士小鼠模型中,甾醇14α-去甲基酶(CYP51)抑制剂VNI和VFV的抗锥虫活性
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02098-16. Print 2017 Apr.
2
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.真菌CYP51抑制剂VT-1161和VT-1129对临床分离的对唑类和棘白菌素类抗真菌化合物耐药的光滑念珠菌和克柔念珠菌菌株表现出强大活性。
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01817-16. Print 2017 Mar.
3
咪康唑与度米芬溴化物联合使用对耐药菌生物膜具有杀菌作用
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.01296-20.
4
Identification of novel antifungal agents: antimicrobial evaluation, SAR, ADME-Tox and molecular docking studies of a series of imidazole derivatives.新型抗真菌剂的鉴定:一系列咪唑衍生物的抗菌评估、构效关系、药物代谢动力学-毒理学及分子对接研究
BMC Chem. 2019 Aug 6;13(1):100. doi: 10.1186/s13065-019-0623-6. eCollection 2019 Dec.
In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51.2-(1H-咪唑-1-基)-1-苯基乙醇衍生物作为抗原生动物药物的体外筛选及对克氏锥虫CYP51的对接研究
Eur J Med Chem. 2016 May 4;113:28-33. doi: 10.1016/j.ejmech.2016.02.028. Epub 2016 Feb 15.
4
In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent.通过计算机模拟和体外筛选来鉴定结构多样的非唑类CYP51抑制剂作为强效抗真菌剂。
J Mol Graph Model. 2016 Jan;63:1-7. doi: 10.1016/j.jmgm.2015.10.014. Epub 2015 Oct 31.
5
A Nano-MgO and Ionic Liquid-Catalyzed 'Green' Synthesis Protocol for the Development of Adamantyl-Imidazolo-Thiadiazoles as Anti-Tuberculosis Agents Targeting Sterol 14α-Demethylase (CYP51).一种用于开发金刚烷基-咪唑并噻二唑作为靶向甾醇14α-脱甲基酶(CYP51)的抗结核药物的纳米氧化镁和离子液体催化的“绿色”合成方案。
PLoS One. 2015 Oct 15;10(10):e0139798. doi: 10.1371/journal.pone.0139798. eCollection 2015.
6
VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.VFV作为一种用于治疗恰加斯病和内脏利什曼病的新型有效CYP51结构衍生药物候选物。
J Infect Dis. 2015 Nov 1;212(9):1439-48. doi: 10.1093/infdis/jiv228. Epub 2015 Apr 15.
7
History of the Harvard ChemDraw project.哈佛化学绘图项目的历史。
Angew Chem Int Ed Engl. 2014 Oct 13;53(42):11140-5. doi: 10.1002/anie.201405820. Epub 2014 Aug 11.
8
Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition.针对克氏锥虫固醇14α-脱甲基酶的抑制剂合理设计的结构基础:酶分子的两个区域增强其抑制作用。
J Med Chem. 2014 Aug 14;57(15):6704-17. doi: 10.1021/jm500739f. Epub 2014 Jul 29.
9
Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents.基于 4-氨基吡啶的抑制剂针对克氏锥虫 CYP51 的理性开发作为抗恰加斯病药物。
J Med Chem. 2013 Oct 10;56(19):7651-68. doi: 10.1021/jm401067s. Epub 2013 Sep 30.
10
CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds.细胞色素P450 51(CYP51)的结构以及基于结构开发新型病原体特异性抑制性支架。
Int J Parasitol Drugs Drug Resist. 2012 Dec;2:178-186. doi: 10.1016/j.ijpddr.2012.06.001. Epub 2012 Jun 30.